Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-04-25
2006-04-25
Ungar, Susan (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Reexamination Certificate
active
07034112
ABSTRACT:
The present invention relates to MDK1 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing.Methods for treatment, diagnosis, and screening are provided for diseases or conditions characterized by an abnormality in a signal transduction disorder. The signal transduction pathway involves an interaction between a MDK1 receptor tyrosine kinase and a receptor for the kinase. The MDK1 receptor tyrosine kinase may be truncated and lack a kinase domain and may be selected from the group consisting of MDK1.T1, MDK1.T2, MDK1.Δ1 and MDK1.Δ2.
REFERENCES:
patent: 3691016 (1972-09-01), Patel et al.
patent: 3969287 (1976-07-01), Jaworek et al.
patent: 4195128 (1980-03-01), Hildebrand et al.
patent: 4229537 (1980-10-01), Hodgins et al.
patent: 4247642 (1981-01-01), Hirohara et al.
patent: 4330440 (1982-05-01), Ayers et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5457048 (1995-10-01), Pasquale et al.
patent: 5504000 (1996-04-01), Littman et al.
patent: 5521295 (1996-05-01), Pacifici et al.
patent: 5981246 (1999-11-01), Fox et al.
patent: 2003/0105000 (2003-06-01), Pero et al.
patent: 93/00425 (1993-01-01), None
patent: 9323429 (1993-11-01), None
patent: 9323569 (1993-11-01), None
patent: 95/28484 (1995-10-01), None
Aaronson, “Growth Factors and Cancer,”Science254:1146-1153 (1991).
Abe et al., “Molecular Characterization of a Novel Metabotropic Glutamate Receptor mGluR5 Coupled to Inositol Phosphate/Ca2+Signal Transduction,”J. Biol, Chem. 267:13361-13368 (1992).
Adelman et al., “In Vitro Deletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone,”DNA2(3):183-193 (1983).
Basier and Hafen, “Ubiquitous Expression of sevenless: Position-Dependent Specification of Cell Fate,”Science243:931-934 (1989).
Benoist and Chambon, “In vivo sequence requirements of the SV40 early promoter region,”Nature290:304-310 (1981).
Bird et al., “Single-Chain Antigen-Binding Proteins,”Science242:423-426 (1988).
Bitter et al., “Expression and Secretion Vectors for Yeast,”Methods in Enzym. 153:516-544 (1987).
Böhme et al., “PCR mediated detection of a new human receptor-tyrosine-kinase, HEK 2,”Oncogene8:2857-2862 (1993).
Brinster et al., “Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs,”Proc. Natl. Acad. Sci. USA82:4438-4442 (1985).
Capecchi, “Altering the Gonome by Homologous Recombination,”Science244:1288-1292 (1989).
Chabot et al., “The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W location,”Nature335:88-89 (1988).
Chan and Walt, “eek and erk, new members of the eph subclass of receptor protein-tyrosine kinases,”Oncogene6:1057-1061 (1991).
Chen and Okayama, “High-Efficiency Transformation of Mammalian Cells by Plasmid DNA,”Mol. and Cell, Biol. 7(8):2745-2752 (1987).
Chomczynski and Sacchi, “Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction,”Analytical Biochemistry162:156-159 (1987).
Chowdhury et al., “Long-term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient Rabbits,”Science254:1802-1805 (1991).
Ciossek et al., “Identification of alternatively spliced mRNAs encoding variants of MDK1, a novel receptor tyrosine kinase expressed in the murine nervous system,”Oncogene10(1):97-108 (1995).
Colbère-Garapin et al., “A New Dominant Hybrid Selective Marker for Higher Eukaryotic Cells,”J. Mol. Biol. 150:1-14 (1981).
Cole et al., “The EBV-Hybridoma Technique and its Application to Human Lung Cancer,” pp. 77-96 inMonoclonal Antibodies and Cancer Therapyeds. Reisfeld and Sell, Alan R. Liss, Inc., New York (1985).
Creighton,Proteins: Structures and Molecular Principlespp. 79-86, W.H. Freeman and Co., New York, (1983).
Cristiano et al., “Hepatic Gene Therapy: Adenovirus Enhancement of Receptor-Mediated Gene Delivery and Expression in Primary Hepatocytes,”Proc. Natl. Acad. Sci, USA90:2122-2126 (1993).
Curlel et al., “Adenovirus Enhancement of Transferrin-polylysine-mediated Gene Delivery,”Proc. Natl. Acad. Sci. USA88:8850-8854 (1991).
Curiel et al., “Gene Transfer to Respiratory Epithelial Cells via the Receptor-mediated Endocytosis Pathway,”Am. I. Resoir, Cell, Mol. Biol. 6:247-252 (1992).
Domchek et al., “Inhibition of SH2 Domain/Phosphoprotein Association by a Nonhydrolyzable Phosphonopeptide,”Biochemistry31:9865-9870 (1992).
Ellis et al., “Embryo Brain Kinase: a novel gene of the eph/elk receptor XP002002321 tyrosine kinase family,”EMBL Database entry MMBEK, Acccession No. X81466, Sep. 16, 1994).
Fantl et al., “Distinct Phosphotyrosines on a Growth Factor Receptor Bind to Specific Molecules That Mediate Different Signaling Pathways,”Cell69:413-423 (1992).
Feinberg and Vogelstein, “A Techique for Radiolabeling DNA Restriction Endonuclease Fragments to High Specific Activity,”Analytical Biochemistry132:6-13 (1983).
Felder et al., “SH2 Domains Exhibit High-Affinity Binding to Tyrosine-Phosphorylated Peptides Yet Also Exhibit Rapid Dissociation and Exchange,”Mol. and Cell: Biol. 13(3):1449-1455 (1993).
Felgner and Ringold, “Cationic liposome-mediated transfection,”Nature337:387-388 (1989).
Felgner et al., “Lipofection: A Highly Efficient, Lipid-mediated DNA-transfection Procedure,”Proc. Natl. Acad. Sci. USA84:7413-7417 (1987).
Fendly et al., “Characterization of Murine Monoclonal Antibodies Reactive to Either the Human or Epidermal Growth Factor Receptor or HER2
eu Gene Product”Cancer Research50:1550-1558 (1990).
Fingl and Woodbury, Chapter 1, pp. 1-46 inThe Pharmacological Basis of Therapeutics(5th edition),eds. Goodman et al., MacMillan Publishing Co., Inc., New York (1975).
Fry et al., “New insights into protein-tyrosine kinase receptor signaling complexes,”Protein Science2:1785-1797 (1993).
Geissler et al., “The Dominant-White Spottling (W) Locus of the Mouse Encodes the c-kit Proto-Oncogene,”Cell55:185-192 (1988).
Gilardi-Hebenstreit et al., “An Eph-related receptor protein tyrosine kinase gene segmentally expressed in the developing mouse hindbrain,”Oncogene7:2499-2506 (1992).
Hamer and Walling, “Regulation In Vivo of a Cloned Mammalian Gene: Cadmium Induces the Transcription of a Mouse Metallothionein Gene in SV40 Vectors,”J. of Molecular and Applied Genetics1:273-288 (1982).
Hammer et al., “Spontaneous Inflammatory Disease in Transgenic Rats Expressing HLA-B27 and Human β2m: An Animal Model of HLA-B27-Associated Human Disorders,”Cell63:1099-1112 (1990).
Hanks et al., “The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains,”Science241:42-52 (Jul. 1988).
Hardle, “Roles of Protein Kinases and Phosphatases in Signal Transduction,”Symp. Soc. Exp. Bio. 44:241-255 (1990).
Hirai et al., “A Novel Putative Tyrosine Kinase Receptor Encoded by the eph Gene,”Science238:1717-1720 (1987).
Houdebine and Chourrout, “Transgenesis in Fish,”Experientia47:891-897 (1991).
Huston et al., “Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced inEscherichia coli,” Proc. Natl. Acad. Sci. USA85:5879-5883 (1988).
Inouye and Inouye, “Up-promotor mutations in the Ipp gene ofEscherichia coli,” Nucleic Acids Research13(9):3 100-3111 (1985)
Ciossek Thomas
Millauer Birgit
Ullrich Axel
Foley & Lardner LLPO
Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
Ungar Susan
LandOfFree
Methods for diagnosis and treatment of MDK1 signal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for diagnosis and treatment of MDK1 signal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosis and treatment of MDK1 signal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3560749